Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene

被引:14
|
作者
Karimzadeh, Parvaneh [1 ]
Naderi, Samaneh [2 ]
Modarresi, Farzaneh [3 ]
Dastsooz, Hassan [4 ]
Nemati, Hamid [7 ]
Farokhashtiani, Tayebeh [1 ]
Shamsian, Bibi Shahin [5 ]
Inaloo, Soroor [6 ]
Faghihi, Mohammad Ali [3 ]
机构
[1] Shahid Beheshti Univ Med Sci SBMU, Pediat Neurol Dept, Pediat Neurol Res Ctr, Tehran, Iran
[2] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran
[3] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA
[4] Shiraz Univ Med Sci, Comprehens Med Genet Ctr, Shiraz, Iran
[5] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran
[6] Shiraz Univ Med Sci, Neonatal Res Ctr, Shiraz, Iran
[7] Shiraz Univ Med Sci, Shiraz Neurosci Res Ctr, Shiraz, Iran
来源
BMC MEDICAL GENETICS | 2017年 / 18卷
关键词
GM1; gangliosidosis; GLB1; Case report; BETA-GALACTOSIDASE DEFICIENCY; GM1-GANGLIOSIDOSIS; PATHOGENESIS; FAMILIES; DISEASE;
D O I
10.1186/s12881-017-0417-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Type II or juvenile GM1-gangliosidosis is an autosomal recessive lysosomal storage disorder, which is clinically distinct from infantile form of the disease by the lack of characteristic cherry-red spot and hepatosplenomegaly. The disease is characterized by slowly progressive neurodegeneration and mild skeletal changes. Due to the later age of onset and uncharacteristic presentation, diagnosis is frequently puzzled with other ataxic and purely neurological disorders. Up to now, 3-4 types of GM1-gangliosidosis have been reported and among them type I is the most common phenotype with the age of onset around 6 months. Various forms of GM1-gangliosidosis are caused by GLB1 gene mutations but severity of the disease and age of onset are directly related to the position and the nature of deleterious mutations. However, due to its unique genetic cause and overlapping clinical features, some researchers believe that GM1 gangliosidosis represents an overlapped disease spectrum instead of four distinct types. Case presentation: Here, we report a less frequent type of autosomal recessive GM1 gangliosidosis with perplexing clinical presentation in three families in the southwest part of Iran, who are unrelated but all from " Lurs" ethnic background. To identify disease-causing mutations, Whole Exome Sequencing (WES) utilizing next generation sequencing was performed. Four patients from three families were investigated with the age of onset around 3 years old. Clinical presentations were ataxia, gate disturbances and dystonia leading to wheelchair-dependent disability, regression of intellectual abilities, and general developmental regression. They all were born in consanguineous families with no previous documented similar disease in their parents. A homozygote missense mutation in GLB1 gene (c. 601 G > A, p. R201C) was found in all patients. Using Sanger sequencing this identified mutation was confirmed in the proband, their parents, grandparents, and extended family members, confirming its autosomal recessive pattern of inheritance. Conclusions: Our study identified a rare pathogenic missense mutation in GLB1 gene in patients with complex neurodevelopmental findings, which can extend the list of differential diagnoses for childhood ataxia in Iranian patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Major Mutation p.His281Tyr in Gene GLB1 in Patients with GM1-Gangliosidosis in Ukraine
    Mytsyk, N. Y.
    Olkhovych, N. V.
    Gorovenko, N. G.
    CYTOLOGY AND GENETICS, 2017, 51 (04) : 263 - 267
  • [22] Gene editing to treat GM1-gangliosidosis by heterotopic insertion of GLB1 in a murine model
    Przybilla, Michael
    Ou, Li
    Jarnes-Utz, Jeanine R.
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S131 - S131
  • [23] Prevention of murine GM1-gangliosidosis following heterotopic insertion of Glb1 using gene editing
    Przybilla, Michael
    Sidhu, Rohini
    Kell, Pamela
    Seelig, Davis
    Jiang, Xuntian
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S101 - S101
  • [24] BETA-GALACTOSIDASE GENE MUTATION IN A CHILD WITH SEVERE JUVENILE GM1 GANGLIOSIDOSIS
    KAYE, EM
    SHALISH, C
    BREAKEFIELD, XO
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 911 - 911
  • [25] Adeno-Associated Viral (AAV) Vector-Mediated GLB1 Gene Transfer Reduces Substrate Accumulations in a Murine Model of GM1 Gangliosidosis
    Ni, Yan G.
    Gelb, Michael
    Herbst, Zachary
    Vrentas, Catherine
    Messick, Elyse
    Weinstein, David A.
    Browne, Susan E.
    Wilson, James M.
    Hinderer, Christian
    MOLECULAR THERAPY, 2023, 31 (04) : 388 - 388
  • [26] Beta-galactosidase deficiencies and novel GLB1 mutations in three Chinese patients with Morquio B disease or GM1 gangliosidosis
    Lei, Hong-Lin
    Ye, Jun
    Qiu, Wen-Juan
    Zhang, Hui-Wen
    Han, Lian-Shu
    Wang, Yu
    Gu, Xue-Fan
    WORLD JOURNAL OF PEDIATRICS, 2012, 8 (04) : 359 - 362
  • [27] Beta-galactosidase deficiencies and novel GLB1 mutations in three Chinese patients with Morquio B disease or GM1 gangliosidosis
    Hong-Lin Lei
    Jun Ye
    Wen-Juan Qiu
    Hui-Wen Zhang
    Lian-Shu Han
    Yu Wang
    Xue-Fan Gu
    World Journal of Pediatrics, 2012, 8 : 359 - 362
  • [28] Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America
    Santamaria, R.
    Blanco, M.
    Chabas, A.
    Grinberg, D.
    Vilageliu, L.
    CLINICAL GENETICS, 2007, 71 (03) : 273 - 279
  • [29] A duplication in the canine β-galactosidase gene GLB1 causes exon skipping and GM1-gangliosidosis in Alaskan huskies
    Kreutzer, R
    Leeb, T
    Müller, G
    Moritz, A
    Baumgärtner, W
    GENETICS, 2005, 170 (04) : 1857 - 1861
  • [30] In vitro expression studies of 11 mutations identified in the GLB1 gene of GM1-gangliosidosis patients.
    Caciotti, A
    Zammarchi, E
    Bardelli, T
    Bisanzi, S
    Donati, MA
    D'Azzo, A
    Morrone, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 631 - 631